Smith Godfrey
Institute of Biomedical and Life Sciences IBLS, University of Glasgow, Glasgow G12 8QQ, UK.
Exp Physiol. 2007 Nov;92(6):973-86. doi: 10.1113/expphysiol.2007.034314.
Heart failure as a result of a myocardial infarction (MI) is a common condition with a poor prognosis. The adaptive changes in the surviving myocardium appear to be insufficient in terms of both mechanical/contractile performance and electrical stability. The modification of the underlying myocardial physiology is complex, varying across the different layers within the wall of the ventricle and within one layer. Two therapeutic strategies are briefly discussed, as outlined here. (i) Enhancing contractility by alteration of the expression of a single protein (e.g. sarco-endoplasmic reticulum Ca(2+) ATPase, SERCA) could potentially reverse both mechanical and electrical abnormalities. However, experimental data involving the upregulation of SERCA suggest that the therapeutic range of this approach is narrow. (ii) The use of regular exercise training to improve cardiac performance in heart failure. This appears to act by normalizing a number of aspects of myocardial physiology.
心肌梗死(MI)导致的心力衰竭是一种常见疾病,预后较差。就机械/收缩性能和电稳定性而言,存活心肌中的适应性变化似乎并不充分。潜在心肌生理学的改变很复杂,在心室壁的不同层以及同一层内都有所不同。如下简要讨论两种治疗策略。(i)通过改变单一蛋白质(如肌浆网Ca(2+)ATP酶,SERCA)的表达来增强收缩力,可能会逆转机械和电异常。然而,涉及SERCA上调的实验数据表明,这种方法的治疗范围较窄。(ii)使用规律运动训练来改善心力衰竭患者的心脏功能。这似乎是通过使心肌生理学的多个方面正常化来发挥作用的。